• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.69% Nasdaq Down 1.07%

    RXi Pharmaceuticals Corporation (RXII)

    -NasdaqCM
    0.40 Up 0.01(1.52%) Aug 31, 4:00PM EDT
    Add to Portfolio
    Prev Close:0.40
    Open:0.44
    Bid:0.38 x 2000
    Ask:0.43 x 8000
    1y Target Est:3.00
    Beta:1.70183
    Earnings Date:Nov 11 - Nov 16 (Est.)
    Day's Range:0.40 - 0.44
    52wk Range:0.34 - 3.98
    Volume:2,045,968
    Avg Vol (3m):1,584,210
    Market Cap:26.04M
    P/E (ttm):N/A
    EPS (ttm):-0.41
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for RXII

    Comparison

    Symbol% ChgMkt Cap
    RXIIUp 1.52%26.04M
    AGNDown 1.39%119.56B
    ALNYDown 5.65%8.71B
    MRNAUp 5.06%10.98M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):400.86
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.22
    Quarterly EPS Est (Sep-15) :-0.04
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering and developing therapies primarily in the areas of dermatology and ophthalmology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback